The Innovation and Technology Payment (ITP) 2019/20 was launched at Expo 2018 on 5 September 2018. This programme supports NHS England’s commitment to accelerate the adoption and spread of proven and affordable innovations, as set out in the Five Year Forward View and NHS Long Term Plan. The ITP aims to remove financial and procurement barriers to support the NHS to adopt innovative medical devices, diagnostics, and digital products.
To be selected for the ITP, products needed to meet the following criteria:
- NICE support (through a Medtech Innovation Briefing or Guidance)
- Positive in-year return on investment
- Use in at least three NHS organisations
These criteria focus the ITP on proven innovations with in-year return on investment that are ready for national adoption. For this year, the following themes are being supported from 1 April 2019:
- Non-invasive vagus nerve stimulation therapy for the treatment of cluster headaches.
- Absorbable spacer to reduce rectum radiation exposure during prostate radiation therapy.
- Placental growth factor (PIGF) based test for the rule‑out of pre‑eclampsia.
- High sensitivity troponin assay in a rapid rule out protocol for acute myocardial infarction.
Additionally, two themes will be supported through the Evidence Generation Fund. These themes will have a more limited roll-out with more intensive evaluation support.
- Digital apps to support emergency/crisis mental health assessments.
- Interoperable personal health record tool.
- The Innovation and Technology Payment (ITP) 2019/20 builds on the Innovation and Technology Tariff (ITT) and ITP 2018/19. It supports the NHS in adopting innovation by removing some of the financial or procurement barriers which can inhibit uptake at scale.
- It is a competitive process designed to scale up adoption of innovations and technologies that have already proved their clinical effectiveness and are ready for nationwide spread.
- The ITP’s focus is to support a range of cost effective medical devices, digital platforms and technologies within our budgetary confines and will have a wide-reaching impact on patient care, deliver savings to the NHS and maximise learning from the programme while fostering culture change.
- The ITP programme forms part of a wider set of activities to support innovation in the NHS, led by NHS England and delivered with the support of the Academic Health Science Network.
- The implementation of any agreed payment mechanism or procurement is operational from 1 April 2019.
- Day-to-day support and reporting will be via NHS England’s Innovation, Research and Life Sciences Unit.
The Innovation Technology Tariff of 2017/18 and the Innovation Technology Payment 2018/19 will continue to be supported during 2019/20. Details of these innovations can be found in the technical notes posted on this page during June 2019.